- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Kanion & Huawe Medicine Co.,Ltd
Total 1068 results
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedPrimary HypercholesterolemiaChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Shandong Suncadia Medicine Co., Ltd.Enrolling by invitation
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Biliary Tract Carcinoma | Advanced Primary Liver CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSmall-cell Lung CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHER2-positive Recurrent / Metastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMature B Cell NeoplasmsChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedDiabetes Mellitus, Type 2China
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingNeoplasm Malignant | Tumor, Solid | Cancer, MetastaticChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHER2 Positive Metastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHepatic ImpairmentChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSevere Aplastic AnemiaChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedNasopharyngeal CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingExtensive-stage Small Cell Lung CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedNon-small Cell Lung Cancer(NSCLC)China
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHuman Immunodeficiency Virus InfectionChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHealthy SubjectsChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedRheumatoid ArthritisChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingAcute Vulvovaginal CandidiasisChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingGastric Cancer | GastroEsophageal CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Jiangsu HengRui Medicine Co., Ltd.WithdrawnIntrahepatic Cholangiocarcinoma
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHealthy Adult Male VolunteersChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHealthy Subjects, Drug-drug Interaction, PyrotinibChina
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Jiangsu HengRui Medicine Co., Ltd.UnknownSafety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Liver FunctionHealthy Subjects | Hepatic ImpairmentChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedColorectal Cancer Metastatic | Colorectal Cancer RecurrentChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHepatic Impairment | Healthy Participants
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHealthy Adult SubjectsChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownDrug-drug Interaction,SHR3680China